SEC Company Response from Century Therapeutics, (IPSC) — Feb 17, 2026
Century Therapeutics, Inc.
Date: Feb. 17, 2026 · CIK: 0001850119 · Accession: 0001104659-26-016115
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-293228
Letter
Century Therapeutics, Inc.
North 38 th Street, 11 th Floor Philadelphia, Pennsylvania 19104
February 17, 2026
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549-7553
Re: Century Therapeutics, Inc.
Registration Statement on Form S-3
Filed February 5, 2026, 2026 (File No. 333-293228)
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Century Therapeutics, Inc. (the " Company ") hereby requests that the effective date of the Company's Registration Statement on Form S-3 (File No. 333-293228) (the " Registration Statement ") be accelerated so that the Company's Registration Statement will become effective at 4:05 P.M., Eastern Time, on January 17, 2026, or as soon thereafter as is practicable.
Please contact Jennifer Porter, Esq. of Goodwin Procter LLP, counsel to the Company, at (445) 207-7806 to provide notice of effectiveness, or if you have any questions or comments concerning this request.
[ Remainder of the page intentionally left blank ]
Very truly yours,
CENTURY THERAPEUTICS, INC.
Show Raw Text
CORRESP 1 filename1.htm Century Therapeutics, Inc. 25 North 38 th Street, 11 th Floor Philadelphia, Pennsylvania 19104 February 17, 2026 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549-7553 Re: Century Therapeutics, Inc. Registration Statement on Form S-3 Filed February 5, 2026, 2026 (File No. 333-293228) Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Century Therapeutics, Inc. (the " Company ") hereby requests that the effective date of the Company's Registration Statement on Form S-3 (File No. 333-293228) (the " Registration Statement ") be accelerated so that the Company's Registration Statement will become effective at 4:05 P.M., Eastern Time, on January 17, 2026, or as soon thereafter as is practicable. Please contact Jennifer Porter, Esq. of Goodwin Procter LLP, counsel to the Company, at (445) 207-7806 to provide notice of effectiveness, or if you have any questions or comments concerning this request. [ Remainder of the page intentionally left blank ] Very truly yours, CENTURY THERAPEUTICS, INC. By: /s/ Brent Pfeiffenberger, Pharm.D. Name: Brent Pfeiffenberger, Pharm.D. Title: President and Chief Executive Officer